Hints and tips:
Related Special Reports
Related Topics
US biotech has been struggling to overcome fall in demand for coronavirus jabs
Companies have yet to provide investors with convincing post-pandemic strategies
...On Monday, Disney said it was “hopeful Charter is ready to have more conversations that will restore access to its content to Spectrum customers as quickly as possible”....
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...Similarly, more must be done by the global health community to ensure that a full spectrum of appropriate antibiotics is available, especially given the rise in antimicrobial resistance....
US healthcare company is putting cash to work from spinning off its consumer health arm
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...Tim Harford (“The planet’s got 99 problems, but exponential growth isn’t one”, Spectrum, FT.com, January 13) may be right about economists’ understanding of mathematics....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...continue to be committed to the principle that we must have diverse viewpoints on our programs, and to that end, we will redouble our efforts to seek voices that represent different parts of the political spectrum...
...It seems surprising that the artist, who has described himself as “the last black and white, conventional, traditional photographer”, should have plunged so deeply into the full spectrum....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
...PIKs have always been at the risky end of the high yield spectrum, and MainFT has tended to strike a cautious tone around pretty much any firm that issues them, quoting one banker calling them a “Hail Mary...
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
Millions of Paxlovid pills have gone unused as tight controls restrict access
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
Investor worries about the impact of weight loss drugs on food companies are overdone
...Last summer, ESPN was briefly blacked out for some US customers of Charter Communications’ Spectrum cable service over such a dispute between Disney and the distributor, limiting access to US Open tennis...
...It is an investor across the private equity spectrum, from venture capital to large buyout groups....
...Teresa Graham, chief of Roche’s pharmaceutical division, said more patients suffered from diseases of the immune system than from cancer, and the current drugs did not serve them well....
International Edition